Generics Bulletin Explains: The Changing US Generics Market
Price Pressures Are Abating Amid Portfolio Pruning, Market Exits And Shortages
After a couple of years of heavy downwards pressure on US generics prices, prominent off-patent companies have pointed to a change in the pricing environment as several factors combine to reduce price erosion. Meanwhile, some firms are benefiting from first generic launches as others exit the market altogether, while injectables shortages continue to loom large.
